Weil Advised Cornell Capital in its Acquisition of Advancing Eyecare

Weil advised Cornell Capital in its acquisition of Advancing Eyecare, a provider of ophthalmic instruments. The transaction closed on June 13, 2022.

The Weil team that advised Cornell Capital was led by Private Equity partner Christopher Machera and included Private Equity associates Theodora TavridouThomas FormanNicole Hellman and Ryan Divers (Not Yet Admitted in New York). The team also included Tax partner Jason Vollbracht; Tax associate Josh Schonfeld; Banking & Finance Co-Head Andrew Colao; Banking & Finance associates Amrita MukherjeeAlan Wen and Claudia Stantzyk-Guzek; Executive Compensation & Benefits partner Jennifer Britz; Executive Compensation & Benefits associate Ace Szmolyan (Not Yet Admitted in New York); Technology & IP Transactions partner Michael Epstein; Technology & IP Transactions/Privacy counsel Olivia Greer and Alexa Chu Clinton; Technology & IP Transactions/Privacy associates Audrey NicolsonDavid Merck and Amanda DeMasi; Environmental Head Annemargaret Connolly; Regulatory Transactions counsel John O’Loughlin and Timothy Welch; Regulatory Transactions associates Ariel Fliman and Christina Carone (Admitted in New York Only); Antitrust counsel Michael Naughton and Alexis Brown-Reilly; Employment Litigation counsel Ami Zweig; and Employment Litigation associate Sahar Merchant.